Cibc Bancorp Usa Inc. Amneal Pharmaceuticals, Inc. Transaction History
Cibc Bancorp Usa Inc.
- $80.8 Billion
- Q3 2025
A detailed history of Cibc Bancorp Usa Inc. transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Cibc Bancorp Usa Inc. holds 16,041 shares of AMRX stock, worth $184,952. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,041Holding current value
$184,952% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding AMRX
# of Institutions
257Shares Held
148MCall Options Held
194KPut Options Held
49.3K-
Vanguard Group Inc Valley Forge, PA18MShares$207 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$142 Million6.02% of portfolio
-
Rubric Capital Management LP New York, NY11.7MShares$135 Million2.18% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$130 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.62MShares$64.9 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.75B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...